PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 97 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2017. The put-call ratio across all filers is 6.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,300,000 | +32.1% | 391,993 | -2.1% | 0.01% | +83.3% |
Q2 2022 | $1,741,000 | -27.2% | 400,532 | +52.4% | 0.01% | -25.0% |
Q1 2022 | $2,392,000 | -89.0% | 262,858 | -75.2% | 0.01% | -89.2% |
Q4 2021 | $21,722,000 | +946.3% | 1,061,696 | +1206.6% | 0.07% | +957.1% |
Q3 2021 | $2,076,000 | -31.9% | 81,257 | -6.8% | 0.01% | -46.2% |
Q2 2021 | $3,049,000 | +101.4% | 87,197 | +91.8% | 0.01% | +160.0% |
Q1 2021 | $1,514,000 | +232.0% | 45,465 | -69.5% | 0.01% | +25.0% |
Q1 2020 | $456,000 | -63.3% | 149,000 | -37.9% | 0.00% | -50.0% |
Q4 2019 | $1,242,000 | +91.4% | 239,831 | +90.8% | 0.01% | +100.0% |
Q3 2019 | $649,000 | -32.1% | 125,700 | -20.4% | 0.00% | -42.9% |
Q2 2019 | $956,000 | +29.9% | 157,976 | +58.8% | 0.01% | +133.3% |
Q4 2018 | $736,000 | +35.3% | 99,472 | -4.0% | 0.00% | -40.0% |
Q3 2017 | $544,000 | +157.8% | 103,662 | +245.5% | 0.01% | +25.0% |
Q2 2016 | $211,000 | +305.8% | 30,000 | +200.0% | 0.00% | – |
Q4 2013 | $52,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madrone Advisors, LLC | 16,415,933 | $218,331,909 | 38.11% |
ORACLE INVESTMENT MANAGEMENT INC | 2,015,495 | $26,806,084 | 19.75% |
Decheng Capital Management III (Cayman), LLC | 1,463,872 | $19,469,498 | 6.11% |
Iron Triangle Partners LP | 2,400,000 | $31,920,000 | 4.27% |
Jackson Square Partners, LLC | 8,517,624 | $113,284,399 | 3.30% |
BOURNE LENT ASSET MANAGEMENT INC | 580,000 | $7,714,000 | 2.69% |
ARK Investment Management | 26,634,620 | $354,240,443 | 2.34% |
ARDSLEY ADVISORY PARTNERS LP | 906,000 | $12,049,800 | 2.04% |
Avidity Partners Management LP | 4,337,400 | $57,687,420 | 2.02% |
Nikko Asset Management Americas, Inc. | 13,649,948 | $181,271,309 | 1.91% |